BDMD Stock Analysis: Buy, Sell, or Hold?
BDMD - Baird Medical Investment Holdings Ltd Ordinary Share
$0.45
-0.01 (-1.66%)
▼
5d:
-21.29%
30d:
-42.88%
90d:
-57.77%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When BDMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BDMD is down 21.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BDMD is down 21.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BDMD is currently trading at $0.45, which is considered oversold relative to its 30-day fair value range of $0.56 to $0.91. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.2) compared to its historical average (6.1). Remarkably, the market is currently pricing in an annual earnings decline of 19.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BDMD is in a strong downtrend. Immediate support is located at $0.40, while resistance sits at $0.80.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+797.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDMD is in a strong downtrend. Immediate support is located at $0.40, while resistance sits at $0.80.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.00 (+797.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.56 -
$0.91
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 797.9% below Wall St target ($4.00)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.56 -
$0.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.40
Resistance Level
$0.80
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.18
Wall Street Target
$4.00
(+797.9%)
Revenue Growth (YoY)
24.6%
Earnings Growth (YoY)
-0.3%
Profit Margin
-65.1%
Valuation Discount vs History
-19.3% cheaper
PE vs Historical
3.2 vs 6.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-19.3%
(market-implied from PE analysis)
1-Year Target
$0.40
(-10%)
2-Year Target
$0.36
(-19%)
3-Year Target
$0.32
(-27%)
3-Yr Target (if PE normalizes)
(PE: 3→6)
$0.62
(+40%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 75.0%)
$9.38
(+2006%)
Base:
(SPY PE: 3.2, Growth: 75.0%)
$1.50
(+238%)
Bear:
(PE: 2.7, Growth: 75.0%)
$1.28
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.2 to 6.1
Stabilization Target:
$0.85
(+91.7%)
PE Expansion Potential:
+91.7%
Share & Embed Analysis
Last updated: October 24, 2026 3:39 AM ET
Data refreshes hourly during market hours. Next update: 4:39 AM
Data refreshes hourly during market hours. Next update: 4:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 41 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 37 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 38 SELL |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 70 BUY |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$167 | 37 SELL |